3179 related articles for article (PubMed ID: 23074453)
1. Left ventricular assist devices: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
[TBL] [Abstract][Full Text] [Related]
2. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
[TBL] [Abstract][Full Text] [Related]
3. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ventricular assist device programme in the UK.
Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
[TBL] [Abstract][Full Text] [Related]
6. HeartMate left ventricular assist device as bridge to heart transplantation.
Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
9. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
[TBL] [Abstract][Full Text] [Related]
11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
12. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
13. Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(3):1-90. PubMed ID: 32190164
[TBL] [Abstract][Full Text] [Related]
14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
15. Total artificial hearts: bridge to transplantation.
Copeland JG; Arabia FA; Tsau PH; Nolan PE; McClellan D; Smith RG; Slepian MJ
Cardiol Clin; 2003 Feb; 21(1):101-13. PubMed ID: 12790049
[TBL] [Abstract][Full Text] [Related]
16. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
[TBL] [Abstract][Full Text] [Related]
17. Right and left ventricular assist devices are an option for bridge to heart transplant.
Barac YD; Toledano R; Jawitz OK; Schroder JN; Daneshmand MA; Patel CB; Aravot D; Milano CA
JTCVS Open; 2022 Mar; 9():146-159. PubMed ID: 36003474
[TBL] [Abstract][Full Text] [Related]
18. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
[TBL] [Abstract][Full Text] [Related]
19. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
[TBL] [Abstract][Full Text] [Related]
20. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
